Agreed the SP has remained [$270 - $330] rangebound for a period of time but when the companies pipeline is studied you will find in that same period significant advances have been made.
Once these therapies [one or two underway carry blockbuster potential] hit a Phase III trial, pass the futility tests, and come before the FDA for approval; the SP will appreciate considerably. The low $300's will seem like a golden opportunity missed.
Even the bread and butter stuff like flu vaccines are now being seen as of benefit to folks, and there are a lot of them out there, who always remained skeptical of the science behind innoculation...and you can always count on the Australian dollar to tank at some point.
Agreed the SP has remained [$270 - $330] rangebound for a period...
-
- There are more pages in this discussion • 544 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$285.10 |
Change
-6.060(2.08%) |
Mkt cap ! $138.0B | |||
| Open | High | Low | Value | Volume |
| $289.85 | $291.99 | $285.10 | $215.2M | 748.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2976 | $285.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $286.53 | 75 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |